Clinical Trial Update: Study of Netarsudil Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of netarsudil ophthalmic solution in primary open angle glaucoma or ocular hypertension has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• netarsudil ophthalmic solution (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Primary Open Angle Glaucoma or Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2019-06-11